Use of low-intensity laser therapy for treatment and prevention of oral mucositis lesions in a leukemic patient: Case report
DOI:
https://doi.org/10.33448/rsd-v13i10.47015Keywords:
Laser therapy, Mucositis, Leukemia.Abstract
Leukemias are malignant hematologic neoplastic diseases that result from the uncontrolled growth of clonal cells in the bone marrow. The treatment of leukemias has important side effects, among them, oral mucositis (OM), the most common complication in the oral cavity, presenting inflammation of the mucosa, erythema and painful ulcers. A therapy already widely disseminated in the literature due to its numerous positive results in the treatment of OM, is low-intensity laser therapy (LLLT), which has beneficial effects on the irradiated tissues. The present study aims to report a clinical case where LLLT was used for the treatment and prevention of OM lesions in a patient with acute promyelocytic leukemia. Patient M.S.S, 40 years old, presented intense dryness of the oral mucosa at the beginning of chemotherapy, so an opinion was requested for evaluation by the Hospital Dentistry team. During clinical examination, multiple ulcerated lesions were observed in the oral mucosa. Therefore, the approach adopted was to use Flogoral spray, artificial saliva and initiate the laser therapy protocol for the management of OM. LLI demonstrated significant results, with clinical improvement, pain minimization and tissue regeneration. The patient continued to be monitored in the remaining chemotherapy cycles for the laser therapy protocol to prevent OM. OM is a condition that affects not only the patient's quality of life, but can also have repercussions on antineoplastic treatment. Therefore, LLI may be a treatment of choice for OM in cancer patients, so far, without presenting any side effects.
Downloads
References
Almeida, S. C. (2015). Leucemia promielocítica aguda: clínica, diagnóstico e abordagem [Dissertação de Mestrado]. Faculdade de Medicina de Coimbra. https://hdl.handle.net/10316/36531. https://estudogeral.uc.pt/handle/10316/36531.
Anschau, F., Webster, J., Capra, M. E. Z., Silva, A. L. F.A, & Stein, A. T. (2019). Efficacy of low-level laser for treatment of cancer oral mucositis: a systematic review and meta-analysis. Lasers in medical science, 34(6), 1053–1062. https://doi.org/10.1007/s10103-019-02722-7
Barillari, M. E., Goulart, M. N., & Gomes, A. C. P. (2015). Complicações das terapias antineoplásicas: Prevenção e tratamento da mucosite oral. Investigação, 14 (6), 121-124.
Bensadoun, R. J., & Nair, R. G. (2012). Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: 2012 state of the art based on literature review and meta-analysis. Current opinion in oncology, 24(4), 363–370. https://doi.org/10.1097/CCO.0b013e328352eaa3
Cingam, S. R., & Koshy, N. V. (2023). Acute Promyelocytic Leukemia. In StatPearls. StatPearls Publishing.
Centurion, B. S., Garcias, A. S., Rubira-Bullen, I. R. F., & Santos, P. S. S. (2012). Avaliação clínica e tratamento das complicações bucais pós quimioterapia e radioterapia. Revista da Associacao Paulista de Cirurgioes Dentistas, 66(2), 136-141.
Curra, M., Soares Junior, L. A. V., Martins, M. D., & Santos, P. S. da S.. (2018). Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein (são Paulo), 16(1), eRW4007. https://doi.org/10.1590/S1679-45082018RW4007
Elad, S., Cheng, K. K. F., Lalla, R. V., Yarom, N., Hong, C., Logan, R. M. … Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) (2020). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 126(19), 4423–4431. https://doi.org/10.1002/cncr.33100
Fiwek, P., Irga-Jaworska, N., Wojtylak, S., Biernat, W., Emerich, K., & Pomiecko, D. (2023). Assessment of Cytological Changes in the Oral Mucosa in Young Hematological Patients Treated with Systemic Chemotherapy. Journal of Clinical Medicine, 12(7), 2665. https://doi.org/10.3390/jcm12072665.
Gautam, A. P., Fernandes, D. J., Vidyasagar, M. S., & Maiya, G. A. (2012). Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients - a randomized controlled trial. Oral oncology, 48(9), 893–897. https://doi.org/10.1016/j.oraloncology.2012.03.008
Genot, M. T., & Klastersky, J. (2005). Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy. Current opinion in oncology, 17(3), 236–240. https://doi.org/10.1097/01.cco.0000156196.22249.76
Jácomo, R. H., Figueiredo-Pontes, L. L. D., & Rego, E. M. (2008). Do paradigma molecular ao impacto no prognóstico: uma visão da leucemia promielocítica aguda. Revista da Associação Médica Brasileira, 54, 82-89. https://doi.org/10.1590/S0104-42302008000100026.
Maria, O. M., Eliopoulos, N., & Muanza, T. (2017). Radiation-induced oral mucositis. Frontiers in oncology, 7, 89. https://doi.org/10.3389/fonc.2017.00089. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2017.00089/full.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica.
Reolon, L. Z., Rigo, L., Conto, F. D., & Cê, L. C. (2017). Impacto da laserterapia na qualidade de vida de pacientes oncológicos portadores de mucosite oral. Revista de Odontologia da UNESP, 46, 19-27.
Rodríguez-Caballero, A., Torres-Lagares, D., Robles-García, M., Pachón-Ibáñez, J., González-Padilla, D., & Gutiérrez-Pérez, J. L. (2012). Cancer treatment-induced oral mucositis: a critical review. International journal of oral and maxillofacial surgery, 41(2), 225-238.
Salles Filho, A. S., & Campos, H. O. (2022). Efeitos colaterais associados ao tratamento da Leucemia Promielocítica Aguda: revisão sistemática. Research, Society and Development, 11(3), e45711326914-e45711326914.
Sandoval, R. L., Koga, D. H., Buloto, L. S., Suzuki, R., & Dib, L. L. (2003). Manejo da mucosite oral induzida por quimioterapia e radioterapia com laser de baixa potência: resultados iniciais do Hospital AC Camargo. Journal of Applied Oral Science, 11(4), 337-341.
Santos, P. S. D. S., Messaggi, A. C., Mantesso, A., & De Magalhães, M. H. C. G. (2009). Mucosite oral: perspectivas atuais na prevenção e tratamento. RGO: Revista Gaúcha de Odontologia, 57(3). https://pesquisa.bvsalud.org/portal/resource/pt/lil-527917.
Singh, V., & Singh, A. K. (2020). Oral mucositis. National journal of maxillofacial surgery, 11(2), 159-168.
Silva, D. V. P. L., Ribeiro, L. V. S., dos Santos, M. G., Pereira, J. M. L., da Silva Freire, J., Andrade, R. D. C. D. V., ... & de Freitas, M. D. C. A. (2022). Eficácia da laserterapia no tratamento da mucosite oral em pacientes com cec de língua: relato de caso. Studies in health sciences, 3(1), 73-82.
Silva, J. A. T., Pereira, G. L., Verner, F. S., & Pigatti, F. M. (2021). Ação da laserterapia em lesões de mucosite oral: série de casos. HU Revista, 47, 1-6. https://doi.org/10.34019/1982-8047.2021.v47.34104.
Tomita, A., Kiyoi, H., & Naoe, T. (2013). Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As 2 O 3) in acute promyelocytic leukemia. International journal of hematology, 97, 717-725.
Zerbini, M. C. N., Soares, F. A., Morais, J. C., Vassallo, J., Velloso, E. D. R. P., Chaufaille, M. D. L. L., ... & Paes, R. P. (2011). Classificação dos tumores hematopoéticos e linfoides de acordo com a OMS: padronização da nomenclatura em língua portuguesa, 4ª edição. Jornal Brasileiro de Patologia e Medicina Laboratorial, 47, 643-648.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Lucas Andeilson dos Santos Matos; Erika Queiroga Ramalho; Francisco Willame da Silva; Camila de Oliveira Lôbo; Isaac Müller de Sousa Maia; Ivyna Maria Cardins Falcão; Carla Welch da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
